【兵庫県南東部】小児科／クリニック管理医師（院長）

【兵庫県】MD求人

勤務地

兵庫県内

給与

1400万円 応相談

募集科目

一般内科、小児科、その他（アレルギー科、免疫科）、製薬会社

勤務内容

その他
対象科目：内科、小児科、アレルギー科、免疫科

Basic purpose of the job
Senior CPhL-Asia supports the clinical development in Asia of new drugs and further development of approved drugs with emphasis on the design and execution of the Clinical Pharmacology (CP)development strategy.
CPhL-Asia is accountable and responsible for communicating with regulatory authorities on CP topics and for CP aspects of drug submission in Asia (e.g., submission summaries).
CPhL-Asia may act as trial clinical Pharmacologist (TCP; see TCP job profile) for clinical studies in their own project or outside of their own projects.
CPhL-Asia may serve as Clin Pharm representative within various teams in Asia (Japan/China) in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia will also serve as main TMCP representatives in all PMO projects in Asia.

Accountabilities
Ensure timely delivery of state-of-the-art Clinical Pharmacology scientific concepts for decision making throughout clinical drug development and registration in Asia including all necessary processes and documentation.
Ensures timely delivery of state-of-the-art Clinical Pharmacology strategy development and implementation.
Senior CPhL-Asia is responsible for defining the CP strategy (for instance, defining the drug-drug interaction liability or formulation development strategy for modified release) of assigned project. CPhL-Asia is also responsible for refining the CP strategy in a timely manner as new data become available during drug development. As part of the strategy, CPhL-Asia may define CP aspects in a clin trial protocol and for an eventual submission and further phase IV activities.
Senior CPhL-Asia contributes to the Clin Pharm section of official documents (e.g., Information Brochure (IB), label); CPhL-Asia engages with regulatory agencies on matters pertaining to CP during drug development and are responsible for supporting Asian submission and post-submission activities with Clin Pharm and Biopharm expertise.
Clinical development project representative
Act as Clin Pharm representative in trial and project teams and regulatory meetings.
CPhL-Asia serves as Clin Pharm representative within various teams in support of early integration of Japan/China into global development program. Post PoCP, they may serve as CP and TMCP representative in various Asian teams until submission and launch. CPhL-Asia may also serve as main TMCP representatives in all PMO projects in Asia.
When delegating a trial to TCP, a CPhL-Asia is expected to ensure that adequate amount of information on the project and trial are provided to the TCP.
For instance, a CPhL-Asia is expected to discuss study design and project standards with the TCP.
A CPhL-Asia may function as a TCP in certain studies or projects.
Driving science and innovation
CPhL-Asia leads clinical development trial and project overarching topics from TMCP (e.g. by focus group).
CPhL-Asia represents Clinical Pharmacology or TMCP in internal and external initiatives/working groups.
CPhL-Asia continuously scouts, evaluates (incl piloting) and implements new methods and strategies in the area of Clinical Pharmacology.
Strategic partnerships:
CPhL-Asia implements collaborations and strategic partnerships with external bodies. They organize and manage projects with external organizations (e.g. CROs, ARO).
CPhL-Asia may serve as subject matter expert (CP, Biopharm) in in –or outlicensing activities

Functional processes:
CPhL-Asia continuously develops and refines further functional processes and infrastructure.
CPhL-Asia is CP (CP and Biopharm) experts and may offer this expertise to other interface functions (e.g, Toxicology, Pharmacovigilance, Customer Information, Marketing, Regulatory Affairs) or to support internal or external working groups.
CPhL-Asia presents results internally and externally as well as contributes to scientific publications.

Compliance (incl GCP):
CPhL-Asia follows all ICH GCP, other relevant authority regulations and internal guidance to protect the rights, safety and wellbeing of trial subjects, including sample chain of custody, data privacy and data integrity. In addition, obligations outside the field of clinical studies, such as EHS, Pharmacovigilance, anti-corruption, BI-internal guidance should be followed.

• 院長クラス
• オンコールなし
• 未経験歓迎

【兵庫県姫路市】新規開院予定クリニック／管理医師

勤務地

兵庫県姫路市

給与

1500万円 ～ 1700万円 応相談

募集科目

小児科

勤務内容

外来
新規開設予定クリニックの外来診療
・電子カルテ(ユヤマ)

• 院長クラス
• オンコールなし
• 未経験歓迎

【兵庫県姫路市】新規開院予定クリニック／管理医師

勤務地

兵庫県姫路市

給与

1500万円 ～ 1700万円 応相談

募集科目

小児科

勤務内容

外来
新規開設予定クリニックの外来診療
・電子カルテ(ユヤマ)

• 高額年俸
• 外来のみ
• インセンティブ
• 当直なし
• 院長クラス
• オンコールなし

【神戸市】小児科クリニック新規開設に伴う院長職募集

勤務地

兵庫県神戸市

給与

2000万円 ～ 2400万円 応相談

募集科目

小児科

勤務内容

外来
小児科クリニック新規開設に伴う管理医師業務

当院では保険診療をベースの診療内容としつつ、一部小児低身長治療、頭蓋矯正ヘルメット治療等の小児向けの自由診療の導入を予定しております。

【保険診療】
・一般小児科の診療

【自由診療】
・小児低身長治療（成長ホルモン治療）
※患者様ご自身で行っていただく注射での治療になりますので、診察、診断がメインとなります。また診察、診断方針については、当グループ医師よりレクチャーさせていただく予定です
※完全予約制のため、残業時間はほとんど発生いたしません。
・頭蓋矯正ヘルメット治療

【経営に関して】
当院では、医療に専念できる環境づくりを重視しています。医師としての役割はお願い致しますが、経営判断や事務的な運営業務については、専任の運営チームが対応いたします。診療業務に集中していただけるよう、書類業務やスタッフ管理などの負担も最小限となる体制を整えています。